Ready-to-use liquid parenteral formulation for determining cardiac output, hepatic function, liver blood flow, and ophthalmic angiography, comprises indocyanine green, solvent, and excipient or adjuvant
2023-09-30
专利权人RK PHARMA INC (RKPH-Non-standard)
申请日期2023-09-30
专利号IN202341065851-A
成果简介NOVELTY - A ready-to-use liquid parenteral formulation comprises indocyanine green, at least one solvent, and at least one excipient or adjuvant. USE - Ready-to-use liquid parenteral formulation for determining cardiac output, hepatic function, liver blood flow, and ophthalmic angiography. ADVANTAGE - The ready-to-use liquid formulation has improved patient compliance, improved solubility and safety, and can be administered safely and easily without need for reconstitution, and eliminates the need for lyophilization, labor, and/or equipment costs. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for a single dose vial of ready-to-use liquid parenteral formulation, which comprises indocyanine green, ethanol, and sterile water for injection, where the formulation has a pH of 2-8.
IPC 分类号A61B-005/00 ; A61K-031/404 ; A61K-041/00 ; A61K-047/02 ; A61K-047/10 ; A61K-047/18 ; A61K-047/20 ; A61K-009/08
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20171
专题中国科学院新疆生态与地理研究所
作者单位
RK PHARMA INC (RKPH-Non-standard)
推荐引用方式
GB/T 7714
PRASAD V,KOVI R. Ready-to-use liquid parenteral formulation for determining cardiac output, hepatic function, liver blood flow, and ophthalmic angiography, comprises indocyanine green, solvent, and excipient or adjuvant. IN202341065851-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。